14:00-15:45 TAVI Session III – TAVR dilemmas and complications
Πρόεδροι: D. Iliopoulos,G. Hahalis,V. Pyrgakis,S. Tzeis
14:00-14:15 Incidence, predictors and consequences of new LBBB and new PPM after TAVR
14:15-14:30 Is paravalvular regurgitation after TAVR still an important consideration in 2019?
14:30-14:45 A Selective versus Routine Minimalist Strategy. Is every patient eligible?
14:45-15:00 Management of Coronary Disease in AS Patients: Important Treatment Considerations (When to consider CABG, timing of PCI and TAVR, and completeness of revascularization)
15:00-15:15 To crack or not to crack? The role for fracturing bioprosthetic valves during ViV procedures
15:15-15:30 Live-in-a-box TAVR
Σχολιαστές: I. Chlorogiannis,K. Dimitriadis,A. Zacharoulis